List view / Grid view

News

First-in-human study of CMV vaccine HB-101 starts

20 July 2016 | By Victoria White, Digital Content Producer

Hookipa Biotech has announced the start of a first-in-human study to evaluate the safety and immunogenicity of HB-101 against human cytomegalovirus...

Applications invited to join the NICE Board

15 July 2016 | By National Institute for Health and Care Excellent (NICE)

NICE is advertising for five Non-Executive Directors to help NICE improve outcomes for people using the NHS, public health and social care services...

EC approves Revlimid for mantle cell lymphoma

15 July 2016 | By Victoria White, Digital Content Producer

Celgene’s Revlimid (lenalidomide) has been approved by the EC for the treatment of adult patients with relapsed or refractory mantle cell lymphoma...